Genoscience Pharma
PrivateLast Round
Strategic
Dec 17, 2021
Total Funding Raised
$8.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Genoscience Pharma operates in Healthcare & Life Sciences and is based in Marseille. Its latest recorded funding round was a Strategic round in December 2021.
Genoscience Pharma is a biotechnology company that develops small molecule therapeutics for the treatment of cancer and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genoscience Pharma Comparables
Compare Genoscience Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ability Pharmaceuticals | 87% | |
| Genfit S.A. | 81% | |
| Beijing HebaBiz Biotechnology Co., Ltd. | 79% |
For institutional investors. Book with your work email.
Genoscience Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 17, 2021 | ||||
| Grant | Jul 22, 2020 |
For institutional investors. Book with your work email.
Genoscience Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 93% MoM.
- Dec 8, 2025
Monthly visitors grew 2322% MoM, from 49 to 1.2K.
For institutional investors. Book with your work email.
Genoscience Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genoscience Pharma's valuation, stock price, and market status.
Is Genoscience Pharma a public or private company?
Genoscience Pharma is a private company.
What is the current stock price of Genoscience Pharma?
Genoscience Pharma is a private company, so its shares have no public market price. Caplight tracks Genoscience Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genoscience Pharma worth (valuation)?
Valuation information for Genoscience Pharma is not publicly available.
Can I buy Genoscience Pharma stock?
Genoscience Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genoscience Pharma's last funding round?
Genoscience Pharma's most recent funding round was Strategic on December 17, 2021.
Who are the main investors in Genoscience Pharma?
Key investors in Genoscience Pharma include Bpifrance.
Will Genoscience Pharma IPO soon?
No public IPO plans have been announced for Genoscience Pharma.
How can I track Genoscience Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Genoscience Pharma's shares on secondary markets.